How should the use of the DecisionDx-Melanoma test be integrated into clinical practice to potentially avoid sentinel lymph node biopsy?

For which clinical stages is this approach most appropriate?

Answer from: Medical Oncologist at Community Practice

At this time, DecisionDx should be used as an extra piece of molecular information, not for clinical decision-making. The study done on DecisionDx was mainly retrospective, not prospective, so it has limited value in guiding patient care at this time. I would base your decision on SLBx on the curren...

Comments

Medical Oncologist at Advocate Aurora Health
I agree with this opinion and would also say that ...

Please select the option that best describes you:

How should the use of the DecisionDx-Melanoma test be integrated into clinical practice to potentially avoid sentinel lymph node biopsy?

Related Questions